Hypertriglyceridemia and megacystis-microcolon-intestinal hypoperistalsis syndrome

Journal of Pediatric Gastroenterology and Nutrition

Volumn 47, Issue 4, 2008, Pages 507-513

  Pohl, John ^a,d,e,f   Chandra, Richa ^b   Corpuz, Goddy ^a   McNeal, Catherine ^c   Macfarlane, Ronald ^b  

^a Departments of Pediatrics   (United States)

^b Departments of Internal Medicine   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d Section of Pediatric Gastroenterology Hepatology and Nutrition   (United States)

^e White Memorial Medical Group   (United States)

^f TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; CREATININE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL DISTENSION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; APGAR SCORE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL INFECTION; BARIUM ENEMA; BARIUM MEAL; BILIRUBIN BLOOD LEVEL; BLADDER CATHETERIZATION; BLADDER DISTENSION; CASE REPORT; CHOLESTASIS; CHOLESTEROL BLOOD LEVEL; COLOSTOMY; CREATININE BLOOD LEVEL; DECOMPRESSION; ECHOGRAPHY; ENTEROPATHY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTROSTOMY; HUMAN; HYDRONEPHROSIS; HYDROURETER; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; INTESTINE MOTILITY; INTESTINE SOUND; INTESTINE TRANSPLANTATION; KIDNEY CORTEX; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; MALROTATION SYNDROME; MEGACYSTIS MICROCOLON INTESTINAL HYPOPERISTALSIS SYNDROME; NOSE FEEDING; PANCREAS TRANSPLANTATION; PARENTERAL NUTRITION; PRIORITY JOURNAL; STOMACH MOTILITY; STOMACH TUBE; TRIACYLGLYCEROL BLOOD LEVEL; COLON; CONGENITAL MALFORMATION; DIFFERENTIAL DIAGNOSIS; GASTROINTESTINAL MOTILITY; INFANT; INTESTINE; MULTIPLE MALFORMATION SYNDROME; NEWBORN; PERISTALSIS; SYNDROME; TRANSPLANTATION; TREATMENT OUTCOME;

ABNORMALITIES, MULTIPLE; COLON; DIAGNOSIS, DIFFERENTIAL; FEMALE; GASTROINTESTINAL MOTILITY; HUMANS; HYPERTRIGLYCERIDEMIA; INFANT; INFANT, NEWBORN; INTESTINAL DISEASES; INTESTINES; LIVER TRANSPLANTATION; PANCREAS TRANSPLANTATION; PERISTALSIS; SYNDROME; TREATMENT OUTCOME;

EID: 59649096122     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/mpg.0b013e31811322e5     Document Type: Article

References (30)

1. Berdon W, Baker D, Blanc W, et al. Megacystis-microcolon-intestinal hypoperistalsis syndrome: a new case of intestinal obstruction in the newborn: report of radiologic findings in five newborn girls. Am J Roentgenol 1976;126:957-64.
2. Roy A, Bharucha H, Nevin N, et al. Idiopathic intestinal pseudoobstruction: a familial visceral neuropathy. Clin Genet 1980;18:291-7.
3. Krook P. Megacystis-microcolon-intestinal hypoperistalsis syndrome in a male infant. Radiology 1980;136:649-50.
4. Young I, McKeever P, Brown L, et al. Prenatal diagnosis of the megacystis-microcolon-intestinal hypoperistalsis syndrome. J Med Genet 1989;26:403-6.
5. American Academy of Pediatrics. National Cholesterol Education Program. Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992;89:S525-84.
6. Espinosa IL, McNeal CJ, Macfarlane RD. Method for lipoprotein(a) density profiling by BiEDTA differential density lipoprotein ultracentrifugation. Anal Chem 2006;78:438-44.
7. Hosken BD, Cockrill SL, Macfarlane RD. Metal ion complexes of EDTA: a solute system for density gradient ultracentrifugation analysis of lipoproteins. Anal Chem 2005;77:200-7.
8. Chandra R, Macfarlane RD. Remnant lipoprotein density profiling by CsBiEDTA density gradient ultracentrifugation. Anal Chem2006;78:680-5.
9. Blum H, Beier H, Gross HJ. Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis1987;8:93-9.
10. Havel RJ. McCollum award lecture, 1993: triglyceride-rich lipoproteins and atherosclerosis-new perspectives. Am J Clin Nutr1994;59:795-6.
11. Wilson PW, editor. Atlas of Atherosclerosis: Risk Factors and Treatment. 4th ed, Philadelphia: Current Medicine; 2000.
12. Egeler RM, Shapiro R, Loechelt B, et al. Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol 1996;18:340-5.
13. Reina M, Brunzell JD, Deeb SS. Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes. J Lipid Res 1992;33:1823-32.
14. Brunzell JD, Deeb SS. Familial lipoprotein lipase deficiency, apo C-II deficiency. In: Scriver CR, Beaudet AL, Sly WS, et al. (eds). The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001. pp. 2789-816.
15. Havel RJ. Postprandial hyperlipidemia and remnant lipoproteins. Curr Opin Lipidol 1994;5:102-9.
16. Schmitz G, Mollers C, Richter V. Analytical capillary isotachophoresis ofhuman serumlipoproteins. Electrophoresis 1997;18:1807-13.
17. Fraser R,Dobbs B,Rogers G. Lipoproteins and the liver sieve: the role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis. Hepatology 1995;21:863-74.
18. Le Couteur D, Fraser R, Hilmer S, et al. The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance. Clin Pharmacokinet 2005;44:187-200.
19. Cicognani C, Malavolti M, Morselli-Labate A, et al. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med 1997;157:792-6.
20. Avgerinos A, Kourti A, Chu P, et al. Plasma lipid and lipoprotein response to carbohydrate feeding in cirrhotic patients. J Hepatol1988;6:315-24.
21. Miller JP. Dyslipoproteinaemia of liver disease. Ballieres Clin Endocrinol Metab 1990;4:807-32.
22. Krawinkel MB. Parenteral nutrition-associated cholestasis: what do we know, what can we do? Eur J Pediatr Surg 2004;14:230-4.
23. Forchielli ML, Walger WA. Nutritional factors contributing to the development of cholestasis during total parenteral nutrition. Adv Pediatr 2003;50:245-67.
24. Sirtori C, Calabresi L, Ferrara S, et al. L-carnitine reduces plasma lipoprotein(a) levels in patients with hyper Lp(a). Nutr Metab Cardiovasc Dis 2000;10:247-51.
25. Fraser R, Bosanquet A, Day W. Filtration of chylomicrons by the liver may influence cholesterol metabolism and atherosclerosis. Atherosclerosis 1978;29:113-23.
26. Cachefo A, Boucher P, Dusserre E, et al. Stimulation of cholesterol synthesis and hepatic lipogenesis in patients with severe malabsorption. J Lipid Res 2003;44:1349-54.
27. Paluzzi M, Meguid M. A prospective randomized study of the optimal source of nonprotein calories in total parenteral nutrition. Surgery 1987;102:711-7.
28. Williams RH, editor. Williams Textbook of Endocrinology. 10th ed, Philadelphia: WB Saunders; 2002.
29. Garcia-Fuentes E, Gil-Villarino A, Zafra MF, et al. Influence of fasting status on the effects of coconut oil on chick plasma and lipoprotein composition. J Physiol Biochem 2003;59:101-10.
30. Peinado-Onsurbe J, Blay M, Casadome L, et al. Effect of 24-h food deprivation on lipoprotein composition and oleoyl-estrone content of lean and obese Zucker rats. Eur J Nutr 2001;40:155-60.